Abstract
Our goal is to assess the feasibility of low-intensity ultrasound (US) combined with echocontrast agent microbubbles (MB) to transfect the ciliary muscle which has previously been demonstrated to potentially allow the secretion of therapeutic proteins. Reporter plasmid DNA encoding Gaussia luciferase (pCMV-Gluc-1), containing the LacZ gene (pVAXl-LacZ), alone or mixed with 50 % microbubbles (Artison), were injected into the ciliary muscle of rat eyes, with or without ultrasound exposure. Animals were sacrificed 7 and 30 days after injection to assess the secreted luciferase into ocular fluids using luminometry. The localization of gene expression was investigated by β -galactosidase histochemistry, 7 days after transfection. At day 7, luciferase activity in ocular media was significantly higher in eyes injected with plasmid and treated with MB and US, as compared with eyes treated with US alone or with eyes injected with the plasmid only. US plus microbubbles showed a 2.6-fold increase in luminescence (p <; 0.023) compared with the control non-US treated eyes, β-galactosidase expression was observed in the ciliary region in case of US and MB application, whereas no expression was observed in controls eyes without US application. We demonstrate for the first time the feasibility of in vivo gene transfer, mediated by ultrasound and microbubbles in the ciliary muscle for the intraocular production of secreted proteins in the ocular media.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.